Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stroke

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 141 articles: HTML format Text format

Single Articles

September 2018
1. VAN DOORN S, Rutten FH, O'Flynn CM, Oudega R, et al
   Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.
   Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)33685.
   PubMed     Text format     Abstract available
   
   
   
2. CHEN HL, Cai JY, Zha ML, Liu K, et al
   Does CHA2DS2-VASc score have the discrimination and calibration power in predicting renal function decline?
   Int J Cardiol. 2018;266:161.
   PubMed     Text format    
   
   
   
3. WANG S, Su Z, Zhang Y
   The true prevalence of inappropriate anticoagulation therapy in Chinese patients with a CHA2DS2-VASc score of 0.
   Int J Cardiol. 2018;266:159.
   PubMed     Text format    
   
   
   
4. KADHIM K, Lau DH, Linz D, Sanders P, et al
   Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
   Int J Cardiol. 2018;266:153-154.
   PubMed     Text format    
   
   
   August 2018
5. MULDER BA, Geelhoed B, van der Harst P, Spronk HM, et al
   Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study.
   Int J Cardiol. 2018 Aug 10. pii: S0167-5273(18)34407.
   PubMed     Text format    
   
   
   
6. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
   Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
   Int J Cardiol. 2018;264:64-69.
   PubMed     Text format     Abstract available
   
   
   
7. RUBBOLI A
   Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
   Int J Cardiol. 2018;264:95-96.
   PubMed     Text format    
   
   
   
8. MARIN F, Roldan V
   Oral anticoagulation and comorbidities; too many details for clinical practice?
   Int J Cardiol. 2018;264:93-94.
   PubMed     Text format    
   
   
   July 2018
9. VEDOVATI MC, Giustozzi M, Verdecchia P, Pierpaoli L, et al
   Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
   Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)32719.
   PubMed     Text format     Abstract available
   
   
   
10. RIVA L, Ageno W, Di Pasquale G, Agnelli G, et al
    Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism.
    Int J Cardiol. 2018 Jul 26. pii: S0167-5273(18)32356.
    PubMed     Text format     Abstract available
    
    
    
11. KOBAYASHI N, Hata N, Tsurumi M, Shibata Y, et al
    Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to preinfarction angina in patients with acute myocardial infarction.
    Int J Cardiol. 2018 Jul 18. pii: S0167-5273(18)32180.
    PubMed     Text format     Abstract available
    
    
    
12. BURLACU A, Covic A
    'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
    Int J Cardiol. 2018;262:43-44.
    PubMed     Text format    
    
    
    June 2018
13. SPOSATO LA, Lopes RD
    Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
    Int J Cardiol. 2018;261:99-100.
    PubMed     Text format    
    
    
    
14. PARASKEVAS KI, Naylor AR
    Carotid artery stenosis at the time of coronary artery bypass grafting is a risk factor but not a cause for peri-operative stroke.
    Int J Cardiol. 2018;260:23.
    PubMed     Text format    
    
    
    May 2018
15. VISZLAYOVA D, Brozman M, Langova K, Herzig R, et al
    Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trial.
    Int J Cardiol. 2018 May 26. pii: S0167-5273(18)30634.
    PubMed     Text format     Abstract available
    
    
    
16. SCHOOLING CM, Luo S, Au Yeung SL, Thompson DJ, et al
    Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(17)36101.
    PubMed     Text format     Abstract available
    
    
    April 2018
17. SHENG X, Ding S, Ge H, Sun Y, et al
    Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(17)37021.
    PubMed     Text format     Abstract available
    
    
    
18. BAI J, Shen D, Wang B, Han Q, et al
    Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
    Int J Cardiol. 2018;257:226.
    PubMed     Text format    
    
    
    
19. LI B, Sun C, Qin F, Liu N, et al
    Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Int J Cardiol. 2018;256:39.
    PubMed     Text format    
    
    
    March 2018
20. PICCOLO R, Franzone A, Siontis GCM, Stortecky S, et al
    Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up.
    Int J Cardiol. 2018;255:29-31.
    PubMed     Text format     Abstract available
    
    
    
21. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    
    
    
    February 2018
22. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    
    
    
    
23. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    
    
    
    January 2018
24. JOLOBE OMP
    Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
    Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
    PubMed     Text format    
    
    
    
25. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    
    
    
    
26. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    
    
    
    
27. FERLINI M, Rossini R
    Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage.
    Int J Cardiol. 2018;251:42-44.
    PubMed     Text format     Abstract available
    
    
    
28. WAKABAYASHI K, Ikeda N, Kajimoto K, Minami Y, et al
    Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.
    Int J Cardiol. 2018;250:164-170.
    PubMed     Text format     Abstract available
    
    
    December 2017
29. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    
    
    
    
30. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    
    
    
    
31. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    
    
    
    November 2017
32. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    
    
    
    
33. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    
    
    
    
34. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    
    
    
    
35. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    
    
    
    October 2017
36. WIYEH AB, Ochodo EA, Wiysonge CS, Kakia A, et al
    A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion.
    Int J Cardiol. 2017 Oct 26. pii: S0167-5273(17)35919.
    PubMed     Text format     Abstract available
    
    
    
37. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available
    
    
    
38. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    
    
    
    
39. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    
    
    
    September 2017
40. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available
    
    
    
41. SAMBOLA A, Ruiz-Meana M, Barba I, Del Blanco BG, et al
    Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2017;243:9-14.
    PubMed     Text format     Abstract available
    
    
    
42. TOCCI G, Presta V
    Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications.
    Int J Cardiol. 2017;243:471-472.
    PubMed     Text format    
    
    
    
43. ACAMPA M, Camarri S, Lazzerini PE, Guideri F, et al
    Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis.
    Int J Cardiol. 2017;243:466-470.
    PubMed     Text format     Abstract available
    
    
    
44. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    
    
    
    
45. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    
    
    
    August 2017
46. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
    Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
    PubMed     Text format     Abstract available
    
    
    July 2017
47. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available
    
    
    
48. ROSSELLO X, Huo Y, Pocock S, de Werf FV, et al
    Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
    Int J Cardiol. 2017 Jul 15. pii: S0167-5273(17)32845.
    PubMed     Text format     Abstract available
    
    
    
49. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    
    
    
    
50. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available
    
    
    June 2017
51. LAVI S, Iqbal J, Cairns JA, Cantor WJ, et al
    Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
    Int J Cardiol. 2017 Jun 29. pii: S0167-5273(17)33508.
    PubMed     Text format     Abstract available
    
    
    
52. VIDALE S, Arnaboldi M, Bosio V, Corrado G, et al
    Short-term air pollution exposure and cardiovascular events: A 10-year study in the urban area of Como, Italy.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)31683.
    PubMed     Text format     Abstract available
    
    
    
53. CAPPELLARI M, Bovi P
    Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32629.
    PubMed     Text format     Abstract available
    
    
    
54. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available
    
    
    
55. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
    Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
    PubMed     Text format     Abstract available
    
    
    
56. CARMO J, Ferreira J, Costa F, Carmo P, et al
    Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
    PubMed     Text format     Abstract available
    
    
    
57. ACHILLES A, Mohring A, Dannenberg L, Piayda K, et al
    Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.
    Int J Cardiol. 2017;236:76-81.
    PubMed     Text format     Abstract available
    
    
    
58. MEFFORD M, Safford MM, Muntner P, Durant RW, et al
    Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
    Int J Cardiol. 2017;236:462-465.
    PubMed     Text format     Abstract available
    
    
    
59. CHAIKRIANGKRAI K, Jhun HY, Palamaner Subash Shantha G, Bin Abdulhak A, et al
    Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis.
    Int J Cardiol. 2017;236:473-477.
    PubMed     Text format     Abstract available
    
    
    May 2017
60. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available
    
    
    
61. BECATTINI C, Franco L, Agnelli G
    Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
    Int J Cardiol. 2017;235:200.
    PubMed     Text format    
    
    
    
62. ALEXOPOULOS D
    Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017;234:131.
    PubMed     Text format    
    
    
    
63. SUZUKI M, Takanashi S
    Assessment of clinical severity in patients with infective endocarditis with cardio-embolic strokes.
    Int J Cardiol. 2017;234:140.
    PubMed     Text format    
    
    
    April 2017
64. KWOK CS, Bagur R, Rashid M, Lavi R, et al
    Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34897.
    PubMed     Text format     Abstract available
    
    
    March 2017
65. SHEN L, Song L, Liu B, Li H, et al
    Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(16)33287.
    PubMed     Text format     Abstract available
    
    
    
66. KAIER K, Reinecke H, Schmoor C, Frankenstein L, et al
    Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study.
    Int J Cardiol. 2017 Mar 2. pii: S0167-5273(17)31288.
    PubMed     Text format     Abstract available
    
    
    
67. KLAER J, Mahler A, Scherbakov N, Klug L, et al
    Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
    Int J Cardiol. 2017;230:241-247.
    PubMed     Text format     Abstract available
    
    
    February 2017
68. PROIETTI M, Lip GY
    Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
    PubMed     Text format     Abstract available
    
    
    
69. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
    PubMed     Text format     Abstract available
    
    
    
70. GUIMARAES LF, Stone GW, Caixeta A
    Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
    PubMed     Text format    
    
    
    
71. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
    Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
    PubMed     Text format     Abstract available
    
    
    
72. MODI R, Patted SV, Halkati PC, Porwal S, et al
    CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Int J Cardiol. 2017;228:1002-1006.
    PubMed     Text format     Abstract available
    
    
    
73. YUAN X, Du J, Liu Q, Zhang L, et al
    Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
    Int J Cardiol. 2017;228:958-966.
    PubMed     Text format     Abstract available
    
    
    January 2017
74. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available
    
    
    
75. KO D, Thigpen JL, Otis JA, Forster K, et al
    Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
    Int J Cardiol. 2017;227:808-812.
    PubMed     Text format     Abstract available
    
    
    
76. SUZUKI M, Takanashi S, Ohshima Y, Nagatomo Y, et al
    Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes.
    Int J Cardiol. 2017;227:222-224.
    PubMed     Text format     Abstract available
    
    
    December 2016
77. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
    P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
    PubMed     Text format     Abstract available
    
    
    
78. MUSCOGIURI G, Annweiler C, Duval G, Karras S, et al
    Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke.
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34541.
    PubMed     Text format     Abstract available
    
    
    
79. KAHLERT P, Hildebrandt HA, Patsalis PC, Al-Rashid F, et al
    No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)33752.
    PubMed     Text format     Abstract available
    
    
    November 2016
80. LEE CH, Lin TY, Chang SH, Chen CH, et al
    Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
    Int J Cardiol. 2016;228:771-778.
    PubMed     Text format     Abstract available
    
    
    
81. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
    CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
    Int J Cardiol. 2016;228:286-288.
    PubMed     Text format    
    
    
    
82. WONG CK
    Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
    Int J Cardiol. 2016;227:30-36.
    PubMed     Text format     Abstract available
    
    
    
83. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
    Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
    Int J Cardiol. 2016;227:114-121.
    PubMed     Text format     Abstract available
    
    
    
84. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available
    
    
    
85. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available
    
    
    
86. ZHU W, Fu L, Ding Y, Huang L, et al
    Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
    PubMed     Text format     Abstract available
    
    
    
87. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
    Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
    PubMed     Text format     Abstract available
    
    
    October 2016
88. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
    Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
    PubMed     Text format     Abstract available
    
    
    September 2016
89. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available
    
    
    
90. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available
    
    
    
91. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
    A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
    Int J Cardiol. 2016;224:454-455.
    PubMed     Text format    
    
    
    
92. INDRARATNA P, Tian DH, Yan TD, Doyle MP, et al
    Transcatheter aortic valve implantation versus surgical aortic valve replacement: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;224:382-387.
    PubMed     Text format     Abstract available
    
    
    
93. AKCAY M, Soylu K, Yanik A
    Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
    Int J Cardiol. 2016;224:265-266.
    PubMed     Text format    
    
    
    
94. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
    Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
    Int J Cardiol. 2016;224:139-144.
    PubMed     Text format     Abstract available
    
    
    August 2016
95. KATZ M, Bosworth HB, Lopes RD, Dupre ME, et al
    A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade.
    Int J Cardiol. 2016;224:33-36.
    PubMed     Text format     Abstract available
    
    
    
96. DZIEWIERZ A, Siudak Z, Tokarek T, Rakowski T, et al
    Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry).
    Int J Cardiol. 2016;223:236-238.
    PubMed     Text format    
    
    
    
97. SANI M, Ayubi E, Mansori K, Khazaei S, et al
    Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
    Int J Cardiol. 2016;222:949.
    PubMed     Text format    
    
    
    
98. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
    Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
    PubMed     Text format     Abstract available
    
    
    
99. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
    Oral anticoagulation in octogenarians with atrial fibrillation.
    Int J Cardiol. 2016;223:87-90.
    PubMed     Text format     Abstract available
    
    
    
100. BEDEIR K, Giugliano RP, Ramlawi B
     Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
     Int J Cardiol. 2016;222:615-619.
     PubMed     Text format     Abstract available
     
     
     
101. KIM Y, Lee SH
     Embolic stroke and after-admission atrial fibrillation.
     Int J Cardiol. 2016;222:576-580.
     PubMed     Text format     Abstract available
     
     
     
102. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
     Obesity and atrial fibrillation.
     Int J Cardiol. 2016;223:159-160.
     PubMed     Text format    
     
     
     
103. ELGENDY IY, Mahmoud AN, Mansoor H, Mojadidi MK, et al
     Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?
     Int J Cardiol. 2016;222:441-447.
     PubMed     Text format     Abstract available
     
     
     
104. CANOY D, Cairns BJ, Balkwill A, Wright FL, et al
     Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort.
     Int J Cardiol. 2016;222:1012-1018.
     PubMed     Text format     Abstract available
     
     
     July 2016
105. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
     Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study.
     Int J Cardiol. 2016;222:281-286.
     PubMed     Text format     Abstract available
     
     
     
106. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
     Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
     Int J Cardiol. 2016;223:63-64.
     PubMed     Text format    
     
     
     
107. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
     Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
     Int J Cardiol. 2016;222:430-435.
     PubMed     Text format     Abstract available
     
     
     
108. GARG L, Chen C, Haines DE
     Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
     Int J Cardiol. 2016;222:47-50.
     PubMed     Text format     Abstract available
     
     
     
109. SENOO K, Lip GY
     Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
     Int J Cardiol. 2016;221:379-382.
     PubMed     Text format     Abstract available
     
     
     June 2016
110. PAGNESI M, Martino EA, Chiarito M, Mangieri A, et al
     Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
     Int J Cardiol. 2016;221:97-106.
     PubMed     Text format     Abstract available
     
     
     
111. CHOI EJ, Lee IH, Je NK
     Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
     Int J Cardiol. 2016;220:647-652.
     PubMed     Text format     Abstract available
     
     
     
112. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
     Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
     PubMed     Text format     Abstract available
     
     
     
113. XIA SJ, Du X, Li C, Wu JH, et al
     Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
     Int J Cardiol. 2016;220:284-289.
     PubMed     Text format     Abstract available
     
     
     
114. ROKOS J, Heger M, Stollberger C, Finsterer J, et al
     Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
     Int J Cardiol. 2016;221:383-384.
     PubMed     Text format    
     
     
     
115. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
     Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
     Int J Cardiol. 2016;219:251-256.
     PubMed     Text format     Abstract available
     
     
     
116. COLANTONIO LD, Gamboa CM, Kleindorfer DO, Carson AP, et al
     Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
     Int J Cardiol. 2016;220:122-128.
     PubMed     Text format     Abstract available
     
     
     May 2016
117. TONG Y, Cai L, Zhang YW, Lin L, et al
     Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
     Int J Cardiol. 2016;211:58-60.
     PubMed     Text format    
     
     
     April 2016
118. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
     ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
     Int J Cardiol. 2016;217:128-134.
     PubMed     Text format     Abstract available
     
     
     
119. STOLLBERGER C, Finsterer J, Schneider B
     Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
     Int J Cardiol. 2016;216:186-187.
     PubMed     Text format    
     
     
     
120. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
     Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
     Int J Cardiol. 2016;215:11-13.
     PubMed     Text format    
     
     
     
121. XIE XX, Liu P, Wan FY, Lin SG, et al
     Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
     Int J Cardiol. 2016;208:141-6.
     PubMed     Text format    
     
     
     March 2016
122. KOUNIS NG, Grapsas N, Soufras GD, Lianas D, et al
     Clinical and subclinical leaflet thrombosis in bioprosthetic aortic valves: A manifestation of Kounis syndrome?
     Int J Cardiol. 2016;214:86-87.
     PubMed     Text format    
     
     
     
123. EFTEKHARI A, Damgaard D, Grove EL
     Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
     Int J Cardiol. 2016;214:131-132.
     PubMed     Text format    
     
     
     
124. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
     Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
     Int J Cardiol. 2016;212:311-317.
     PubMed     Text format     Abstract available
     
     
     
125. COLEMAN CI, Tangirala M, Evers T
     Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
     Int J Cardiol. 2016;212:171-173.
     PubMed     Text format    
     
     
     
126. TONG Y, Huang X, Wang Z, Han S, et al
     Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
     Int J Cardiol. 2016;207:297-9.
     PubMed     Text format    
     
     
     
127. DELLBORG M, Eriksson P
     Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
     Int J Cardiol. 2016;207:308-9.
     PubMed     Text format    
     
     
     February 2016
128. YIP HK, Yuen CM, Chen KH, Chai HT, et al
     Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
     Int J Cardiol. 2016;205:133-41.
     PubMed     Text format     Abstract available
     
     
     
129. SEO WK, Kang SH, Jung JM, Choi JY, et al
     Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
     Int J Cardiol. 2016;209:184-189.
     PubMed     Text format     Abstract available
     
     
     
130. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
     Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
     Int J Cardiol. 2016;209:1-6.
     PubMed     Text format     Abstract available
     
     
     
131. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
     Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
     Int J Cardiol. 2016;204:1-3.
     PubMed     Text format    
     
     
     January 2016
132. LEE YJ, Park JK, Uhm JS, Kim JY, et al
     Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
     Int J Cardiol. 2016;203:372-8.
     PubMed     Text format     Abstract available
     
     
     
133. KEFER J, Tzikas A, Freixa X, Shakir S, et al
     Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
     Int J Cardiol. 2016;207:335-340.
     PubMed     Text format     Abstract available
     
     
     
134. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
     Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
     Int J Cardiol. 2016;202:967-74.
     PubMed     Text format     Abstract available
     
     
     
135. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
     Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
     Int J Cardiol. 2016;202:578-85.
     PubMed     Text format     Abstract available
     
     
     November 2015
136. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
     Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
     Int J Cardiol. 2015;203:906-908.
     PubMed     Text format    
     
     
     
137. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
     Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
     Int J Cardiol. 2015;203:1014-1015.
     PubMed     Text format    
     
     
     
138. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
     A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
     Int J Cardiol. 2015;203:785-790.
     PubMed     Text format     Abstract available
     
     
     October 2015
139. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
     Strokes after cardioversion of atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2015;203:269-273.
     PubMed     Text format    
     
     
     
140. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
     New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
     Int J Cardiol. 2015;203:264-266.
     PubMed     Text format    
     
     
     September 2015
141. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
     Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
     Int J Cardiol. 2015;202:589-594.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: